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Background: Mismatch repair proteins (MMRPs) are a group of nuclear enzymes that participate in the repair 
of base mismatches that occur during DNA replication in all proliferating cells. The most studied MMRPs are 
hMSH2 and hMLH1, which are known to be highly expressed in normal tissues. A loss of MMRPs leads to the ac-
cumulation of DNA replication errors in proliferating cells. Ki-67 is a biomarker regarded to be the gold-standard 
tool for determining cell proliferation by immunohistochemical methods. The aim of this study was to investigate 
the immunohistochemical expression of hMLH1, hMSH2 and Ki-67 proteins in ameloblastomas and tooth germs, 
to contribute to the understanding of the development of this odontogenic neoplasm. 
Material and Methods: Immunohistochemical assays to determine the presence of proteins hMSH2, hMLH1 and 
Ki-67 were performed in 80 ameloblastomas (40 solid and 40 unicystic) and five tooth germs. 
Results: Unicystic ameloblastomas showed higher MMRP expression (hMLH1: 62.5 ± 43.4; hMSH2: 83.3 ± 47.8) 
than did solid ameloblastomas (hMLH1: 59.4 ± 13.5; hMSH2: 75.8 ± 40.2). Additionally, the cell proliferation 
index assessed by Ki-67 was inversely proportional to the expression of MMRP. Comparison between tooth 
germs and ameloblastoma revealed significantly higher expression of hMLH1, hMSH2 and Ki-67 in tooth germs 
(p=0.02). 
Conclusions: The differences of MMRP and Ki-67 immunoexpression between ameloblastomas and tooth germ 
suggest that alterations in the MMRP mechanisms could participate in the biological behavior of ameloblastomas. 
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Introduction
The frequency of DNA mutations is minimized by re-
pair systems that recognize and correct errors that oc-
cur during DNA replication; this process is very im-
portant for cell survival. Repair systems can recognize 
mispaired, altered, or missing bases in DNA, as well 
as other structural alterations of the double helix (1). 
Repair genes are classified based on the pathway they 
use to reverse or avoid damage to DNA (recombination 
repair, base excision repair, nucleotide excision repair 
and mismatch excision repair). 
The mismatch repair (MMR) system in human cells 
is composed of at least six genes (msh2, mlh1, msh3, 
pms1, hpms2 and gtbp/msh6); the mismatch repair pro-
teins (MMRPs) are very important for recognition and 
repair of mispairing and slippage errors in DNA synthe-
sis. MMRPs are a group of nuclear enzymes that par-
ticipate in the repair of base-base mismatches in all pro-
liferating cells during DNA replication (2). The proteins 
form complexes (heterodimers) that bind to areas of ab-
normal DNA and initiate its removal. A mismatch is de-
tected by two complexes, hMSH2-GTBP/hMSH6 and 
hMSH2-hMSH3 heterodimers, after interaction with 
hMLH1-hPMS2 heterodimers. Then, an endonuclease 
is activated, which cuts the newly synthesized DNA 
strand that contains the mutation (3,4). In this system, 
the hMSH2 and hMLH1 proteins have been the most 
studied, and it is known that they are highly expressed 
in normal tissues, especially in rapidly renewing human 
cells, such as basal cells of the epidermis and the oral 
mucosa (5,6). A loss of MMRPs allows the accumula-
tion of replication errors in the DNA of proliferating 
cells, particularly in genome areas with short repetitive 
nucleotide sequences, a phenomenon known as mic-
rosatellite instability (MSI) (7). hMLH1 is one of the 
major mismatch DNA repair genes, and its inactivation 
increases MSI in a variety of human cancers, includ-
ing head and neck squamous cell carcinoma (HNSCC) 
(8). Loss of the antimutagenic and antirecombinogenic 
effects of the mismatch repair system may contribute 
to tumorigenesis by elevating both the rate of mutation 
(base substitutions and frame shifts) and mitotic recom-
bination (loss of heterozygosity and chromosomal re-
arrangements) (9). Mutations in these genes have been 
linked to hereditary nonpolyposis colon cancer; and 
they also occur in a variety of sporadic cancers (10). 
The correlation between the loss of MMRP expression 
with the severity of epithelial dysplasia in oral poten-
tially malignant lesions and with the degree of differ-
entiation in oral squamous cell carcinoma has been 
established in previous studies (11,12). The expression 
patterns and roles of MMRP in ameloblastoma are not 
clear at all; there have only been two studies about im-
munoexpression of MMRP in ameloblastomas. The first 
focused on hMLH1 and hMSH2 (13), and the second 
studied hMSH2, hMSH3 and hMSH6 (14). However, 
the results and conclusions varied in several aspects, 
which must be clarified with additional studies.
Because proliferation mechanisms are dysregulated in 
neoplasms, Ki-67 can indicate tumor aggressiveness by 
allowing assessment of the proliferation index, which 
has been associated with expression of the MMR com-
plex (15,16).
Since the development of monoclonal antibodies against 
the hMSH2 protein by Leach et al. in 1996, several 
studies have been performed to determine the utility 
of immunohistochemical detection of MMRP (17). The 
aim of this study was to investigate the expression of 
hMLH1, hMSH2 and Ki-67 proteins in ameloblastomas 
and tooth germs with immunohistochemical methods to 
contribute to the understanding of the development of 
this odontogenic neoplasia.
Material and Methods  
We examined the protein expression patterns of hMSH2, 
hMLH1 and Ki-67 by immunohistochemistry in 80 
ameloblastomas (40 solid and 40 unicystic) and in five 
tooth germs from the Molecular Pathology Area and 
Histology laboratory from Facultad de Odontologia, 
Universidad de la Republica, Uruguay. The research 
project was approved by Ethics Committee number 
091900/000120/06. The authors have read the Decla-
ration of Helsinki and have followed its guidelines in 
this investigation. All tumors were diagnosed by histo-
pathological evaluation of surgical specimens and were 
classified according to the 2017 WHO head and neck 
tumor classification standards (18). All specimens were 
fixed in formalin, pH 7.2, and embedded in paraffin 
wax following standard procedures. Two-μm sections 
were mounted on silanized slides and deparaffinized 
in an oven on 45°C for 30 minutes. Then, the sections 
were deparaffinized with xylene and subsequently re-
hydrated with a graded ethanol series and water. Sec-
tions were immersed in 10 mM sodium citrate buffer 
(pH 6.2) and placed in a pressure cooker for microwave 
antigen retrieval for 5 minutes. Endogenous peroxidase 
activity was blocked by incubation with 0.9% H2O2 for 
5 minutes and then buffered with PBS (pH 7.4). Mouse 
monoclonal primary antibodies against hMLH1 (Clone 
ES05), hMSH2 (clone Clone FE11) and Ki-67 (clone 
MIB-1) antibodies were diluted 1:100, and incubated 
on sections for 45 minutes. After incubation, all slides 
were exposed to avidin-biotin complex and horserad-
ish peroxidase reagents (LSAB Kit; Dako Cytomation, 
Carpinteria, CA) and diaminobenzidine tetrahydro-
chloride (DAB; Sigma-Aldrich, St Louis, MO). Finally, 
the sections were counterstained with hematoxylin, de-
hydrated in graded alcohol and cleared with xylene. As 
a positive control, sections of human tonsil were used, 
whereas negative controls were obtained by omitting 
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the specific primary antibody. In tooth germs the pres-
ence of the proteins studied was evaluated in the enamel 
organ.
The index of nuclear positivity was obtained using our 
previously described method (19) and was expressed as 
the percentage of positive cells per square millimeter 
of tissue.
To detect mutations in hMLH1 and hMSH2, Next Gen-
eration Sequencing was performed. In this research, we 
used HAM (Human Ameloblastoma) cell lines (HAM1, 
HAM2 and HAM3), which were established from the 
same ameloblastoma case of the mandible (20). 
The results were analyzed by χ2 tests and Spearman 
correlation using SPSS 16.0 statistical software (SPSS 
Professional Statistics, SPSS Inc., Chicago, IL) and 
were considered significant when p≤0.05
Results
The localization of the hMSH2 and hMLH1 staining 
was exclusively nuclear. In ameloblastomas, immuno-
expression was observed in epithelial tumor nests at the 
outer basal and columnar cells, similar to ameloblasts, 
and in the inner angular cells resembling the stellate re-
ticulum (Fig. 1 A-D). In enamel organ of the tooth germ, 
immunoexpression was observed in enamel epithelium 
as well as in the stellate reticulum. No correlation be-
tween clinical data (age, sex, localization and tumor 
size) and MMRPs was found. 
When MMRPs were evaluated in unicystic ameloblas-
tomas, they showed higher expression (hMLH1: 62.5 ± 
43.4; hMSH2: 83.3 ± 47.8) than did solid ameloblasto-
mas (hMLH1: 59.4 ± 13.5; hMSH2: 75.8 ± 40.2). How-
ever, expression of Ki-67 was inversely proportional to 
Fig. 1: Immunohistochemical localization of hMLH1 (A,C), hMSH2 (B,D) and Ki-67 (E) proteins in different 
ameloblastomas. Immunohistochemical expression of hMSH2 protein in tooth germ (F) (immunoperoxidase, 
20x).
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the expression of MMRP, which indicates that lower 
MMRP correlated with a higher Ki-67 index (Fig. 1 E).
Comparison of tooth germs to ameloblastomas revealed 
significantly higher expression of MMRP and Ki-67 in 
tooth germs (p=0.02); (Fig. 1 F).
Expression levels of Ki-67, hMLH1 and hMSH2 in 
ameloblastomas and tooth germs are reported in Table 
1. Spearman correlation values are shown in Table 2. 
No mutations in hMLH1 and hMSH2 were found by 
Next Generation Sequencing in ameloblastoma cell 
lines,(data not shown).
Discussion
Our results indicate that ameloblastomas expressed 
lower levels of both hMSH2 and hMLH1 proteins com-
pared to normal tissue (tooth germs), we also observed 
differences between the expression of these proteins by 
immunohistochemical analysis in solid and unicystic 
variants.
Castrilli et al. reported for the first time the presence of 
MMRP in ameloblastomas, and recently Amaral-Silva 
et al., who also included tooth germ samples in their 
study (13,14). Consistent with these results, we found 
exclusive nuclear localization of hMLH1 and hMSH2. 
In the first study, hMLH1 and hMSH2 immunostaining 
was observed predominantly in the outer layer of tu-
mor nests, whereas in the present study, variable stain-
ing was observed in both the outer/ameloblastic layer 
and stellate inner cells of tumoral nests, similarly to 
the second study, which also showed that MMRP are 
decreased in ameloblastomas in comparison with tooth 
germ, as we found in this study. 
Regarding the association of MMRP with pathogenesis 
or clinical features of ameloblastoma, the first study 
  Cases (n) hMLH1* hMSH2* Ki-67* p value 
SA 40 59.4  ±13.5 75.8   ±40.2 42.8  ±18.4 0.21 
UA 40 62.5  ±43.4 83.3  ±47.8 30.3  ±12.5 0.09 
TG 5 71.5  ±34.6 88.3  ±44.6 68.5  ±33.5 0.02 
 
Table 1: Levels of hMLH1, hMSH2 and Ki-67 expression in ameloblastomas and tooth germs.  TG: 
tooth germ, UA: unicystic ameloblastoma, SA: solid ameloblastoma. *: percentage and standard devia-
tion.
SA UA TG 
Spearman Correlation 
(MMRP/Ki-67) 
r=.537 r= -.633 r = -.050 
p<0.05 p<0.05 p=0.789 
 
Table 2: Spearman correlation between mismatch repair proteins (MMRP) and 
Ki-67 in solid ameloblastoma (SA), unicystic ameloblastoma (UA) and tooth germ 
(TG).
suggested that hMLH1 and hMSH2 do not have a spe-
cific function related to the development and behavior 
of this tumor (13). In contrast, the latest study found a 
correlation between the simultaneous overexpression of 
three MMRP and tumor recurrence (14).
The MMR system is responsible for removing mis-
matched bases caused by spontaneous damage, amina-
tion of bases, oxidation, methylation and errors in the 
replication or recombination processes (1).
The importance of the MMR system is to maintain ge-
nomic stability and reduce mutations during replication. 
Individuals with related MMR mutations often present 
syndromes with tumor predisposition and several types 
of cancer (21).
Defects in this MMR pathway result in an increased 
rate of mutation or MSI, which leads to defects in genes 
that regulate cell proliferation and death (22), thereby 
increasing susceptibility to cancer. Therefore, proper 
activity of this system is essential to preserve normal 
cellular functions. 
The immunoexpression of hMLH1 and hMSH2 has 
been found in various normal tissues (23), and their 
roles have been correlated with normal reparative func-
tions. It is expected that normal tissues express these 
two proteins, as with any normal DNA repair system. In 
fact, in the present study, we found that normal dental 
tissue (tooth germs) shows higher expression of hMLH1 
and hMLH2 compared with neoplastic tissue (amelo-
blastoma). Because the function of both proteins is to 
repair DNA damage, it is not surprising that they are 
present in cells of constantly renewed tissues, such as 
oral keratinocytes (5), and in this case, in embryonic 
cells forming dental tissues.
On the other hand, we found differences between the 
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expression of MMRP and the histological type of 
ameloblastoma. The unicystic type presented higher ex-
pression of hMLH1 and hMSH2 than solid ameloblas-
toma, suggesting that the decrease of MMRP in solid 
ameloblastoma may play a role in its more aggressive 
course by altering the repair mechanisms.  Gene muta-
tions affect protein expression in different ways. Most 
mutations in hMSH2 are protein truncating; conse-
quently, no hMSH2 is detected by immunohistochemis-
try in these cases (24). Decreased expression of hMLH1 
and hMSH2 in ameloblastomas could be result of a gene 
mutation; our group analyzed gene mutation of hMLH1 
and hMSH2 in a HAM cell lines by next-generation se-
quencing, however, no mutations were detected (data 
not shown). This result suggested that gene mutations 
are not the direct cause of the decreased expression of 
hMLH1 and hMSH2 in ameloblastoma.
Modification in the gene expression without alteration 
in the DNA sequence can be due to epigenetic changes, 
which are potentially inherited but also reversible. The 
main epigenetic mechanisms include DNA methyla-
tion and histone acetylation or deacetylation. Recently, 
evidence for frequent MSH2 hypermethylation in Lynch 
Syndrome tumors with MSH2 deficiency was reported 
(25,26). In hereditary cancers, somatic mutation is the 
main mechanism for hMLH1 gene inactivation; in spo-
radic cancers, epigenetic hMLH1 silencing by promoter 
hypermethylation appears to be involved (27,28). For 
HNSCC, it was previously reported that hypermethyl-
ation of the hMLH1 promoter is a mechanism of gene in-
activation, and therefore, loss of protein expression (27).
Another possible pathway to explain our findings is that 
the decreased levels of hMLH1 and hMSH2 protein ex-
pression is affected by the regulation of mRNA by miR-
NAs. It is well known that very small RNAs (~22 base) 
or miRNAs regulate gene expression by base pairing 
with complementary untranslated sequences in target 
mRNA, thereby regulating gene expression. miRNAs 
present variations between malignant and normal cells 
(29,30). Further studies need to be performed in this 
field to confirm or discard this theory for ameloblasto-
mas. 
Interestingly, we observed that as hMLH1 and hMSH2 
expression was higher, the Ki-67 index decreased in 
ameloblastomas; however, this relationship was not 
present in tooth germs, which had high levels of hM-
LH1, hMSH2 and Ki-67. This suggests different impli-
cations for MMRP in tumorigenic mechanisms and in 
the development of normal tissues.
In contrast to the study by Amaral-Silva et al., in which 
no correlation between MMRP and Ki-67 was found 
in ameloblastomas, we observed a negative correlation 
between MMRP and Ki-67, which probably means that 
a lack of proteins associated with DNA repair can be as-
sociated with an increase in cell proliferation and there-
fore tumoral behavior (31). This increase of proliferation 
and decrease of DNA repair proteins, observed marked-
ly in solid ameloblastomas, may contribute to the higher 
aggressiveness of this variant. On the other hand, the 
higher expression of MMRP and Ki-67 in normal od-
ontogenic tissue (tooth germs) is important, considering 
that it is an embryonic tissue with high proliferation, 
which requires more DNA repair system activity.
In summary, we detected a non-mutational decrease of 
hMLH1 and hMSH2 protein levels, along with an in-
creased proliferation rate in ameloblastomas that may 
be associated with tumor behavior (aggressiveness) and 
lead to DNA susceptibility to replication errors. Normal 
odontogenic tissue (tooth germ) presented a high pro-
liferation index and higher expression of hMLH1 and 
hMSH2, which are physiologically necessary to repair 
DNA in all normal proliferative tissues, including em-
bryonic cells. The data obtained in this work provide 
complementary novel information that contributes to 
the understanding of the roles of MMRPs (hMSH2 and 
hMLH1) in the biological behavior of ameloblastomas 
through interactions with Ki-67 expression.
Conclusions
The results suggest that changes in the correlations be-
tween immunoexpression of MMRPs and Ki-67 could 
be related to the biological behavior of ameloblastomas 
and represent a physiologic mechanism in tooth germs.
References
1. Hao-bo L, Ying-Huai Z, Hui-Zhen C, Yong C. Expression of hu-
man DNA mismatch repair protein, hMSH2, in patients with oral 
lichen planus. Exp Therapeutic Med. 2015;9:203-6.
2. Fink D, Nebel S, Aebi S, Zheng H, Kim HK, Christen RD, et 
al. Expression of the DNA mismatch repair proteins hMLH1 and 
hPMS2 in normal human tissues. Br J Cancer. 1997;76:890-3.
3. Leach FS, Polyak K, Burell M, Johnson KA, Hill D, Dunlop MG, 
et al. Expression of the human mismatch gene hMSH2 in normal and 
neoplastic tissues. Cancer Research. 1996;56:235-40.
4. Kunkel TA, Erie DA. DNA mismatch repair. Annu. Rev. Biochem. 
2005;74:681-10.
5. Lo Muzio L, Nocini P, Mignogna MD, Pannone G, Staibano S, 
Procaccini M, et al. Immunocytochemical detection of hMSH2 and 
hMLH1 expression in oral SCC. Anticancer Res. 1999;19:933-40.
6. Fernandes AM, De Souza VR, Springer CR, Cardoso SV, Loyola 
AM, Mesquita RA, et al. Tobacco and inflammation effects in immu-
noexpression of hMSH2 and hMLH1 in epithelium of oral mucosa. 
Anticancer Res. 2007;27:2433-37.
7. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemi-
cal detection of DNA mismatch repair gene proteins. Virchows Arch. 
2004;445:431-41.
8. Wang Y, Zhou X, Song Y, Ji X, Zhang A, Zhang G, et. al. The mis-
match repair gene hPMS1 (human postmeiotic segregation1) is down 
regulated in oral squamous cell carcinoma. Gene. 2013;524:28-34.
9. Kolodner R. Biochemistry and genetics of eukaryotic mismatch 
repair. Genes Dev. 1996;10:1433-42.
10. Edelbrock MA, Kaliyaperumal S, Williams KJ. Structural, mo-
lecular and cellular functions of MSH2 and MSH6 during DNA mis-
match repair, damage signaling and other noncanonical activities. 
Mutat Res. 2013;743-744:53-66. 
11. Jessri M, Dalley AJ, Farah CS. MutSα and MutLα immunoex-
pression analysis in diagnostic grading of oral epithelial dysplasia 
Med Oral Patol Oral Cir Bucal. 2018 Mar 1;23 (2):e126-31.                                                                                                                                               Mismatch repair proteins in ameloblastoma
e131
and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral 
Radiol. 2015;119:74-82.
12. Jessri M, Dalley AJ, Farah CS. Hmsh6: a potential diagnostic 
marker for oral carcinoma in situ. J Clin Pathol. 2015;68:86-90.
13. Castrilli G, Piantelli M, Artese L, Perfetti G, Rubini C, Fioroni 
M, et al. Expression of Hmsh2 Hmlh1 proteins of the human DNA 
mismatch repair system in ameloblastoma. J Oral Pathol Med. 
2001;30:305-8.
14. Amaral-Silva GKD, Sánchez-Romero C, Wagner VP, et al. Prog-
nostic significance of hMSH2, hMSH3, and hMSH6 expression 
in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 
2017;124:286-295.
15. Tumuluri V, Thomas GA, Fraser IS. Analysis of the Ki-67 antigen 
at the invasive tumour front of human oral squamous cell carcinoma. 
J Oral Pathol Med. 2002;31:598-04.
16. Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, 
Mori-Estevez AD, Sánchez-Acuña G. Comparison of the value of 
PCNA and Ki-67 as markers of cell proliferation in ameloblastic tu-
mors. Med Oral Patol Oral Cir Bucal. 2013;18:e174-9.
17. Liu T, Wahlberg S, Burek E, Lindblom P, Rubio C, Lindblom 
A. Microsatellite instability as a predictor of a mutation in a DNA 
mismatch repair gene in familial colorectal cancer. Genes Chrom 
Cancer. 2000;27:17-25.
18. El-Naggar AK, Chan JCK, Grandis JR et al, (Eds.) WHO Classi-
fication of Head and Neck Tumours. ed 4. IARC, Lyon, France; 2017.
19. Bologna-Molina R, Damián-Matsumura P, Molina-Frechero N. 
An easy cell counting method for immunohistochemistry that does 
not use an image analysis program. Histopathology. 2011;59:801-3
20. Hatakeyama S, Mizusawa N, Tsutsumi R, Yoshimoto K, Mizu-
ki H, Yasumoto S, et al. Establishment of human dental epithelial 
cell lines expressing ameloblastin and enamelin by transfection of 
hTERT and cdk4 cDNAs. J Oral Pathol Med. 2011;40:227-34.
21. Mach CM, Kim J, Soibam B, Creighton CJ, Hawkins SM, Zighel-
boim I, et. al. Novel MicroRNAs regulating proliferation and apoptosis 
in uterine papillary serous carcinomas. Cancer Lett. 2013;335:314-22.
22. Santarpia L, Nicoloso M, Calin GA. MicroRNAs: a complex reg-
ulatory network drives the acquisition of malignant cell phenotype. 
Endoc Relat Cancer. 2010;17:F51-75.
23. Amira AT, Mouna T, Ahlem B, Raoudha A, Majid BH, Amel H, 
et al. Immunohistochemical expression pattern of MMR protein can 
specifically identify patients with colorectal cancer microsatellite in-
stability. Tumor Biol. 2014;35:6283-91.
24. Chiaravalli AM, Furlan D, Facco C, Tibiletti MG, Dionigi A, 
Casati B, et al. Immunohistochemical pattern of Hmsh2/Hmlh1 in 
familial and sporadic colorectal, gastric, endometrial and ovarian 
carcinomas with instability in microsatellite sequences. Virchows 
Arch. 2001;438:39-48.
25. Ren R, Ocampo A, Liu GH, Izpisua Belmonte JC. Regulation 
of Stem Cell Aging by Metabolism and Epigenetics. Cell Metab. 
2017;26:460-474.
26. Nagasaka T, Rhees J, Kloor M, Gebert J, Naomoto Y, Boland CR, 
Goel A. Somatic hypermethylation of MSH2 is a frequent event in 
Lynch Syndrome colorectal cancers. Cancer Res. 2010;70:3098-108.
27. Liu K, Zuo C, Luo QK, Suen JY, Hanna E, Fan CY. Promoter hy-
permethylation and inactivation of hMLH1, a DNA mismatch repair 
gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol. 
2003;12:50-6.
28. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecu-
lar mechanisms of mammalian DNA repair and the DNA damage 
checkpoints. Annu Rev Biochem. 2004;73:39-85.
29. Calin GA, Croce CM. MicroRNA signatures in human cancers. 
Nat Rev Cancer. 2006;6:857-66.
30. Liu WJ, Zhao YP, Zhang TP, Zhou L, Cui QC, Zhou WX, et 
al. MLH1 as a direct target of MiR-155 and a potential predictor 
of favorable prognosis in pancreatic cancer. J Gastrointest Surg. 
2013;17:1399-405. 
31. Amaral-Silva GK, Martins MD, Pontes HA, Fregnani ER, Lopes 
MA, Fonseca FP, et al., Mismatch repair system proteins in oral be-
nign and malignant lesions. J Oral Pathol Med. 2017;46:241-245.
Conflicts of Interest
The authors reported no conflicts of interest.
